Can new mRNA vaccine improve survival in India’s toughest cancer?

Pancreatic cancer is not among India’s most common cancers, but it is among the most lethal. It is often detected late, spreads quickly, and remains difficult to treat even with advances in oncology.

That is why a new personalised mRNA vaccine — designed to train the immune system to recognise cancer — is drawing global attention.